A Study of RC48-ADC in Local Advanced or Metastatic Gastric Cancer With the HER2-Overexpression
Clinical trial NCT04714190 · UNKNOWN
Trial details
- NCT number
- NCT04714190
- Sponsor
- RemeGen Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-24
- Primary completion
- 2024-12-01
- Enrollment
- 351
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.